Yilmaz M, Kantarjian H, Ravandi F. Acute promyelocytic leukemia current treatment algorithms. Blood Cancer J. 2021;11:123.
Article PubMed PubMed Central Google Scholar
de Thé H, Pandolfi PP, Chen Z. Acute promyelocytic leukemia: a paradigm for oncoprotein-targeted cure. Cancer Cell. 2017;32:552–60.
Madan V, Shyamsunder P, Han L, Mayakonda A, Nagata Y, Sundaresan J, et al. Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia. Leukemia. 2016;30:1672–81.
Article CAS PubMed PubMed Central Google Scholar
Liu J, Zhu HH, Jiang H, Jiang Q, Huang XJ. Varying responses of PML-RARA with different genetic mutations to arsenic trioxide. Blood. 2016;127:243–50.
Article CAS PubMed Google Scholar
Sanz MA, Fenaux P, Tallman MS, Estey EH, Löwenberg B, Naoe T, et al. Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet. Blood. 2019;133:1630–43.
Article CAS PubMed PubMed Central Google Scholar
Diverio D, Riccioni R, Mandelli F, Lo Coco F. The PML/RAR alpha fusion gene in the diagnosis and monitoring of acute promyelocytic leukemia. Haematologica. 1995;80:155–60.
Raelson JV, Nervi C, Rosenauer A, Benedetti L, Monczak Y, Pearson M, et al. The PML/RAR alpha oncoprotein is a direct molecular target of retinoic acid in acute promyelocytic leukemia cells. Blood. 1996;88:2826–32.
Article CAS PubMed Google Scholar
Tan Y, Wang X, Song H, Zhang Y, Zhang R, Li S, et al. A PML/RARα direct target atlas redefines transcriptional deregulation in acute promyelocytic leukemia. Blood. 2021;137:1503–16.
Article CAS PubMed PubMed Central Google Scholar
de Thé H, Chen Z. Acute promyelocytic leukaemia: novel insights into the mechanisms of cure. Nat Rev Cancer. 2010;10:775–83.
Ko PJ, Dixon SJ. Protein palmitoylation and cancer. EMBO Rep. 2018;19:e46666.
Article PubMed PubMed Central Google Scholar
Jin J, Zhi X, Wang X, Meng D. Protein palmitoylation and its pathophysiological relevance. J Cell Physiol. 2021;236:3220–33.
Article CAS PubMed Google Scholar
Lv K, Ren JG, Han X, Gui J, Gong C, Tong W. Depalmitoylation rewires FLT3-ITD signaling and exacerbates leukemia progression. Blood. 2021;138:2244–55.
Article CAS PubMed PubMed Central Google Scholar
Shao X, Xu A, Du W, Xu T, Huang Y, Xia Z, et al. The palmitoyltransferase ZDHHC21 regulates oxidative phosphorylation to induce differentiation block and stemness in AML. Blood. 2023;142:365–81.
Tohumeken S, Baur R, Böttcher M, Stoll A, Loschinski R, Panagiotidis K, et al. Palmitoylated proteins on AML-derived extracellular vesicles promote myeloid-derived suppressor cell differentiation via TLR2/Akt/mTOR signaling. Cancer Res. 2020;80:3663–76.
Article CAS PubMed Google Scholar
Lu Y, Yan JS, Xia L, Qin K, Yin QQ, Xu HT, et al. 2-Bromopalmitate targets retinoic acid receptor alpha and overcomes all-trans retinoic acid resistance of acute promyelocytic leukemia. Haematologica. 2019;104:102–12.
Article CAS PubMed PubMed Central Google Scholar
Ying M, Shao X, Jing H, Liu Y, Qi X, Cao J, et al. Ubiquitin-dependent degradation of CDK2 drives the therapeutic differentiation of AML by targeting PRDX2. Blood. 2018;131:2698–711.
Article CAS PubMed Google Scholar
Yuan M, Chen X, Sun Y, Jiang L, Xia Z, Ye K, et al. ZDHHC12-mediated claudin-3 S-palmitoylation determines ovarian cancer progression. Acta Pharm Sin B. 2020;10:1426–39.
Article CAS PubMed PubMed Central Google Scholar
Sobas M, Talarn-Forcadell MC, Martínez-Cuadrón D, Escoda L, García-Pérez MJ, Mariz J, et al. PLZF-RARα, NPM1-RARα, and other acute promyelocytic leukemia variants: the PETHEMA Registry experience and systematic literature review. Cancers. 2020;12:1313.
Article CAS PubMed PubMed Central Google Scholar
Zhou F, Xue Y, Yao X, Xu Y. CSS-Palm: palmitoylation site prediction with a clustering and scoring strategy (CSS). Bioinformatics. 2006;22:894–6.
Article CAS PubMed Google Scholar
Xue Y, Chen H, Jin C, Sun Z, Yao X. NBA-Palm: prediction of palmitoylation site implemented in Naïve Bayes algorithm. BMC Bioinform. 2006;7:458.
Malgapo MIP, Linder ME. Substrate recruitment by zDHHC protein acyltransferases. Open Biol. 2021;11:210026.
Article CAS PubMed PubMed Central Google Scholar
Testa U, Grignani F, Barberi T, Fagioli M, Masciulli R, Ferrucci PF, et al. PML/RAR alpha+ U937 mutant and NB4 cell lines: retinoic acid restores the monocytic differentiation response to vitamin D3. Cancer Res. 1994;54:4508–15.
Luo H, Li Q, O’Neal J, Kreisel F, Le Beau MM, Tomasson MH. c-Myc rapidly induces acute myeloid leukemia in mice without evidence of lymphoma-associated antiapoptotic mutations. Blood. 2005;106:2452–61.
Article CAS PubMed Google Scholar
Daniele G, Simonetti G, Fusilli C, Iacobucci I, Lonoce A, Palazzo A, et al. Epigenetically induced ectopic expression of UNCX impairs the proliferation and differentiation of myeloid cells. Haematologica. 2017;102:1204–14.
Article CAS PubMed PubMed Central Google Scholar
Shehata MM, Sallam AM, Naguib MG, El-Mesallamy HO. Overexpression of BAMBI and SMAD7 impacts prognosis of acute myeloid leukemia patients: a potential TERT non-canonical role. Cancer Biomark. 2021;31:47–58.
Article CAS PubMed Google Scholar
Niyonzima N, Rahman J, Kunz N, West EE, Freiwald T, Desai JV, et al. Mitochondrial C5aR1 activity in macrophages controls IL-1β production underlying sterile inflammation. Sci Immunol. 2021;6:eabf2489.
Article CAS PubMed PubMed Central Google Scholar
Ghisi M, Kats L, Masson F, Li J, Kratina T, Vidacs E, et al. Id2 and E proteins orchestrate the initiation and maintenance of MLL-rearranged acute myeloid leukemia. Cancer Cell. 2016;30:59–74.
Article CAS PubMed Google Scholar
Eleveld-Trancikova D, Janssen RA, Hendriks IA, Looman MW, Moulin V, Jansen BJ, et al. The DC-derived protein DC-STAMP influences differentiation of myeloid cells. Leukemia. 2008;22:455–9.
Article CAS PubMed Google Scholar
Zhang M, Zhou L, Xu Y, Yang M, Xu Y, Komaniecki GP, et al. A STAT3 palmitoylation cycle promotes TH17 differentiation and colitis. Nature. 2020;586:434–9.
Article CAS PubMed PubMed Central Google Scholar
Chen X, Niu W, Fan X, Yang H, Zhao C, Fan J, et al. Oct4A palmitoylation modulates tumorigenicity and stemness in human glioblastoma cells. Neuro Oncol. 2023;25:82–96.
留言 (0)